{
    "2020-01-15": [
        [
            {
                "time": "2018-01-02",
                "original_text": "UnitedHealth, Pfizer share gains lead Dow's 150-point climb",
                "features": {
                    "keywords": [
                        "UnitedHealth",
                        "Pfizer",
                        "share gains",
                        "Dow's climb"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Lilly to Launch Cheaper Versions of Humalog KwikPen Insulins",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Cheaper Versions",
                        "Humalog",
                        "KwikPen",
                        "Insulins"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Dow's 75-point climb led by gains in UnitedHealth, Pfizer stocks",
                "features": {
                    "keywords": [
                        "Dow's climb",
                        "UnitedHealth",
                        "Pfizer",
                        "gains"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Is Pfizer Inc. (NYSE:PFE) Trading At A 49% Discount?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Discount",
                        "Trading"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "3 Large-Cap Dividend Stocks to Buy Now for Your 2020 Portfolio",
                "features": {
                    "keywords": [
                        "Large-Cap",
                        "Dividend",
                        "Stocks",
                        "Buy",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Pfizer Eyes IPO of Glaxo Consumer Venture in 3 to 4 Years",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "IPO",
                        "Glaxo",
                        "Consumer Venture"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}